Evidence map›Paper›PMID 23904164›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Functional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cells.

Latifa Chachi, Aarti Shikotra, S Mark Duffy, Omar Tliba, Christopher Brightling, Peter Bradding, Yassine Amrani

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Effects ofPlants (Basel, Switzerland) · 2023
    Article
  4. Article
  5. The chemokine CX3CL1/fractalkine regulates immunopathogenesis during fungal-associated allergic airway inflammation.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. CaBritish journal of pharmacology · 2020
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Latifa ChachiDepartment of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester, LE1 7RH, U.K.
Aarti ShikotraDepartment of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester, LE1 7RH, U.K.
S Mark DuffyDepartment of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester, LE1 7RH, U.K.
Omar TlibaDepartment of Pharmaceutical Sciences, Thomas Jefferson University, Jefferson School of Pharmacy, Philadelphia, PA, USA.
Christopher BrightlingDepartment of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester, LE1 7RH, U.K.
Peter Bradding *Department of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester, LE1 7RH, U.K.
Yassine Amrani *Department of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester, LE1 7RH, U.K.
University of Leicester · GBThomas Jefferson University · US

Funding

Airway Inflammatory Pathways Regulating Glucocorticoid Receptor PhosphorylationR01HL111541 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI TLIBA, OMAR · 2012 to 2021
$3.3M
NHLBI NIH HHS R01 HL111541Wellcome Trust
6 · The paper itself

Abstract

Identifying the factors responsible for relative glucocorticosteroid (GC) resistance present in patients with severe asthma and finding tools to reverse it are of paramount importance. In asthma we see in vivo evidence of GC-resistant pathways in airway smooth muscle (ASM) bundles that can be modeled in vitro by exposing cultured ASM cells to TNF-α/IFN-γ. This action drives GC insensitivity via protein phosphatase 5-dependent impairment of GC receptor phosphorylation. In this study, we investigated whether KCa3.1 ion channels modulate the activity of GC-resistant pathways using our ASM model of GC insensitivity. Immunohistochemical staining of endobronchial biopsies revealed that KCa3.1 channels are localized to the plasma membrane and nucleus of ASM in both healthy controls and asthmatic patients, irrespective of disease severity. Western blot assays and immunofluorescence staining confirmed the nuclear localization of KCa3.1 channels in ASM cells. The functional importance of KCa3.1 channels in the regulation of GC-resistant chemokines induced by TNF-α/IFN-γ was assessed using complementary inhibitory strategies, including KCa3.1 blockers (TRAM-34 and ICA-17043) or KCa3.1-specific small hairpin RNA delivered by adenoviruses. KCa3.1 channel blockade led to a significant reduction of fluticasone-resistant CX3CL1, CCL5, and CCL11 gene and protein expression. KCa3.1 channel blockade also restored fluticasone-induced GC receptor-α phosphorylation at Ser(211) and transactivation properties via the suppression of cytokine-induced protein phosphatase 5 expression. The effect of KCa3.1 blockade was evident in ASM cells from both healthy controls and asthmatic subjects. In summary, KCa3.1 channels contribute to the regulation of GC-resistant inflammatory pathways in ASM cells: blocking KCa3.1 channels may enhance corticosteroid activity in severe asthma.

Indexed as

GlucocorticoidsAdultAsthmaBlotting, WesternBronchiCells, CulturedDrug ResistanceEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryFluorescent Antibody TechniqueHumansImmunohistochemistryIntermediate-Conductance Calcium-Activated Potassium ChannelsMaleMyocytes, Smooth MuscleGlucocorticoidsIntermediate-Conductance Calcium-Activated Potassium ChannelsKCNN4 protein, human

Identifiers

PMID23904164
PMCPMC3753579
OpenAlexW2164734501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.